Health
Sinopharm vaccine for COVID-19 elicits immunity to South Africa variant, but with minor effect – Explica
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus…
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus first found in South Africa, but its effect appeared to be weaker, a study showed laboratory with small samples.
Variants of the virus have raised concerns that they may weaken the effects of vaccines and treatments developed before their emergence.
Twelve serum samples taken from recipients of two vaccines developed by a Sinopharm subsidiary…
-
General23 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News24 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General23 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Noosa News13 hours agoSudden death investigation, Maroochydore – Sunshine Coast